Brief: Australian Clinical Labs Says Negligible COVID Revenue Expected In FY24 Result

Australian Clinical Labs

23/10/2023 02:29

Oct 23 (Reuters) - Australian Clinical Labs Ltd
 ACL.AX :
    * NEGLIGIBLE COVID REVENUE IS EXPECTED IN FY24 RESULT
    * Q1 VOLUME RESULTS IN UNDERLYING CORE BUSINESS SHOW VOLUME
GROWTH
OF 5% OVER PCP
    * WORKFORCE AVAILABILITY AND ACCESS TO SERVICES AFFECTING
HEALTHCARE SERVICE VOLUMES
    * WILL ACHIEVE A SIMILAR EBIT RESULT IN FY24 OF BETWEEN A$65
MILLION  AND A$70 MILLION

Source text for Eikon:  ID:nASXb2N97Y 
Further company coverage:  ACL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))